The invention provides a method of detecting the presence, absence or severity of a disease in a patient wherein said disease is accompanied by decreased level of S-adenosylmethionine, or increased level of S-adenosylhomocysterine, or reduced methylation index comprising: identifying any individual or a patient that is suspected of having said disease or is at risk of having said disease; obtaining a biological sample from said patient; determining the level of SAM in said biological sample using an antibody derived from a hapten analog of SAM, SAH; and correlating the levels of SAM, SAH and MI in said biological sample with the presence, absence, or severity of said disease. The invention also provides methods for determining methylation index in biological fluids which is indicative of the health status of an individual. Additionally, the invention includes colloidal gold test strips and homogenous enzyme immunoassays which are useful for determining S-adenosylmethionine and S-adenosylhomocysteine.
本发明提供了一种检测患者是否患有疾病或疾病严重程度的方法,其中所述疾病伴有
S-腺苷蛋氨酸水平的降低、或 S-
腺苷高
胞嘧啶水平的升高、或甲基化指数的降低,该方法包括确定任何疑似患有所述疾病或有可能患有所述疾病的个人或患者;从所述患者处获取
生物样本;使用源自 S
AM、
SAH 的单体类似物的
抗体确定所述
生物样本中的 S
AM 水平;以及将所述
生物样本中的 S
AM、
SAH 和 MI
水平与所述疾病的存在、不存在或严重程度相关联。本发明还提供了确定
生物液体中甲基化指数的方法,该指数可指示个体的健康状况。此外,本发明还包括胶体
金试纸和均质酶免疫测定法,可用于测定
S-腺苷蛋氨酸和 S-
腺苷高半胱
氨酸。